Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP548764.RAn10noluPa3eQpG9fM-0b7F-rjylB4xgaRWl-aKHD9x4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP548764.RAn10noluPa3eQpG9fM-0b7F-rjylB4xgaRWl-aKHD9x4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP548764.RAn10noluPa3eQpG9fM-0b7F-rjylB4xgaRWl-aKHD9x4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP548764.RAn10noluPa3eQpG9fM-0b7F-rjylB4xgaRWl-aKHD9x4130_provenance.
- NP548764.RAn10noluPa3eQpG9fM-0b7F-rjylB4xgaRWl-aKHD9x4130_assertion description "[Fibroblast growth factor (FGF) signaling can bypass the requirement for estrogen receptor (ER) activation in the growth of ER-positive (ER+) breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548764.RAn10noluPa3eQpG9fM-0b7F-rjylB4xgaRWl-aKHD9x4130_provenance.
- NP548764.RAn10noluPa3eQpG9fM-0b7F-rjylB4xgaRWl-aKHD9x4130_assertion evidence source_evidence_literature NP548764.RAn10noluPa3eQpG9fM-0b7F-rjylB4xgaRWl-aKHD9x4130_provenance.
- NP548764.RAn10noluPa3eQpG9fM-0b7F-rjylB4xgaRWl-aKHD9x4130_assertion SIO_000772 16682955 NP548764.RAn10noluPa3eQpG9fM-0b7F-rjylB4xgaRWl-aKHD9x4130_provenance.
- NP548764.RAn10noluPa3eQpG9fM-0b7F-rjylB4xgaRWl-aKHD9x4130_assertion wasDerivedFrom befree-2016 NP548764.RAn10noluPa3eQpG9fM-0b7F-rjylB4xgaRWl-aKHD9x4130_provenance.
- NP548764.RAn10noluPa3eQpG9fM-0b7F-rjylB4xgaRWl-aKHD9x4130_assertion wasGeneratedBy ECO_0000203 NP548764.RAn10noluPa3eQpG9fM-0b7F-rjylB4xgaRWl-aKHD9x4130_provenance.
- befree-2016 importedOn "2016-02-19" NP548764.RAn10noluPa3eQpG9fM-0b7F-rjylB4xgaRWl-aKHD9x4130_provenance.